Blueprint Medicines Corp (BPMC)

90.46 +0.13 (+0.14%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Blueprint Medicines Historical Sharpe Ratio (5Y)

Historical Sharpe Ratio (5Y) Chart

View Historical Sharpe Ratio (5Y) for BPMC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Historical Sharpe Ratio (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Historical Sharpe Ratio Definition

View Historical Sharpe Ratio Definition
Start Trial

The Sharpe Ratio measures the risk-adjusted return of a security. This is a useful metric for analyzing the return you are receiving on a security in comparison to the amount of volatility expected. The historical sharpe ratio uses historical returns to calculate the return and standard deviation.

Read full definition.

Historical Sharpe Ratio (5Y) Range, Past 5 Years

View Historical Sharpe Ratio (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Historical Sharpe Ratio (5Y) Benchmarks

View Historical Sharpe Ratio (5Y) Benchmarks
Start Trial
Vertex Pharmaceuticals Inc Upgrade
PTC Therapeutics Inc Upgrade
Biomarin Pharmaceutical Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade
SpringWorks Therapeutics Inc Upgrade

Historical Sharpe Ratio (5Y) Related Metrics

Alpha (5Y) Upgrade
Beta (5Y) Upgrade
Annualized Standard Deviation of Monthly Returns (5Y Lookback) Upgrade
Historical Sortino (5Y) Upgrade
Max Drawdown (5Y) Upgrade
Monthly Value at Risk (VaR) 5% (5Y Lookback) Upgrade